5FZ-26568-48945
5 vaccinations
4 coded responses
45 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 895 / NV
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
Q7L-17539-06057
Child or adolescent in my care · Female · 2021-08-12
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-19
Health check-in — day 0, dose 1Feeling: Good · Site: Itching · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-28
- 2021-02-04
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-05-11
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Fibrocystic breast disease, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Fibrocystic breast · Healthcare visit (other): breast health centerMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-17
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-02
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-27
- 2021-11-03
- 2021-11-08
- 2021-12-27
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Our whole household had COVID symptoms in January and all of us are vaccinated. Only one, the youngest tested positive.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-03
Dose 4 — Pfizer-BioNTech
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Abdominal mass, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Lump in abdomen. · Healthcare visit (other): Upcoming appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-09-28
Call successfulNot applicable - Accidental Reporting
-
2022-09-28
Call successfulNot applicable - Accidental Reporting
-
2022-12-27
Dose 5 — Pfizer-BioNTechCo-administered: Other
-
2022-12-27
Survey response — day 0, dose 5MedDRA: Dizziness — Feeling: Fair · Site: Itching · Fatigue or tiredness, NauseaFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Itching · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-12-29
- 2022-12-30
- 2023-01-02
- 2023-01-03
- 2023-01-11
- 2023-01-17
- 2023-01-24
- 2023-01-31
- 2023-02-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-06-03 | Pfizer-BioNTech | No |
| 5 | 2022-12-27 | Pfizer-BioNTech | Other |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-12 | Successful 2022-09-28 |
Not applicable - Accidental Reporting |
| 2022-09-27 | Successful 2022-09-28 |
Not applicable - Accidental Reporting |
Free text
Release 9 — 6 months, dose 2
Release 11 — 6 months, dose 3
Symptoms: Our whole household had COVID symptoms in January and all of us are vaccinated. Only one, the youngest tested positive.
Release 12 — 12 months, dose 3
Release 12 — day 0, dose 5
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal mass | · | · | ✓ |
| SD | Fibrocystic breast disease | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release